𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The impact of the GMO regulations on a UK pharmaceutical company

✍ Scribed by Paul Burke


Publisher
Wiley (John Wiley & Sons)
Year
1995
Tongue
English
Weight
352 KB
Volume
64
Category
Article
ISSN
0268-2575

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


The impact of the EU regulation on UK in
✍ Gabriel Moss QC πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 120 KB πŸ‘ 1 views

Introduction 1. Council Regulation (EC) No.1346/2000 of 29 May 2000 on Insolvency Proceed- ings (''the Regulation'') 1 will actually or potentially aΒ‘ect every type of insolvency proceeding in the UK. This paper will, however, generally conΒ’ne itself to that part of the UK known as England andWales

The impact of environmental regulations
✍ Siva Rama Krishna Valluru; E. Wesley F. Peterson πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 104 KB πŸ‘ 2 views

International trade and global environmental protection have become the objects of intense debate. One aspect of this debate concerns the effects of environmental regulations on international competitiveness. In this article, the impact of environmental regulations on grain trade patterns is examine

The Impact of Genomics' Technologies on
✍ Gary McMaster πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 33 KB πŸ‘ 2 views

Over the past two decades, competition in the pharmaceutical industry has been characterized by three factors: 1. Competitive advantage driven by blockbuster drugs 2. Vertical integration from discovery through sales 3. Peripheral role as suppliers in the health care system In this environment, suc

The possible macroeconomic impact on the
✍ Marcus R. Keogh-Brown; Simon Wren-Lewis; W. John Edmunds; Philippe Beutels; Rich πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 281 KB πŸ‘ 1 views

## Abstract Little is known about the possible impact of an influenza pandemic on a nation's economy. We applied the UK macroeconomic model β€˜COMPACT’ to epidemiological data on previous UK influenza pandemics, and extrapolated a sensitivity analysis to cover more extreme disease scenarios. Analysis

The impact of non-compliance on the cost
✍ Dyfrig A. Hughes; Adrian Bagust; Alan Haycox; Tom Walley πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 122 KB πŸ‘ 1 views

## Abstract Non‐compliance with drug therapies not only limits their effectiveness, but in some instances, is associated with grave clinical sequelae and substantial economic burden. It is important, therefore, to consider non‐compliance in economic evaluations. A review of pharmacoeconomic evaluat